The antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in chronic hepatitis C patients Running title: ANA and chronic hepatitis C

[1]  N. Leung,et al.  Hepatitis B: overview of the burden of disease in the Asia‐Pacific region , 2006 .

[2]  M. Hsieh,et al.  Associations of tumour necrosis factor alpha promoter polymorphisms at position −308 and −238 with clinical characteristics of chronic hepatitis C , 2006, Journal of viral hepatitis.

[3]  Ming‐Lung Yu,et al.  Polymorphism of interferon-gamma gene at position +874 and clinical characteristics of chronic hepatitis C. , 2006, Translational research : the journal of laboratory and clinical medicine.

[4]  C. Dai,et al.  Viral hepatitis and proteinuria in an area endemic for hepatitis B and C infections: another chain of link? , 2006, Journal of internal medicine.

[5]  M. Hsieh,et al.  The role of thyroid autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon‐alpha and ribavirin combination therapy , 2006, Journal of viral hepatitis.

[6]  D. Vergani,et al.  Non-organ-specific autoantibodies in hepatitis C virus infection: do they matter? , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  A. Hall,et al.  Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: correlates of positivity and clinical relevance , 2004, Journal of viral hepatitis.

[8]  F. Lammert,et al.  The presence of non-organ-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis C , 2004, BMC infectious diseases.

[9]  M. Lenzi,et al.  Non-organ-specific autoantibodies in children with chronic hepatitis C: clinical significance and impact on interferon treatment. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  M. Law,et al.  The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection. , 2003, Journal of hepatology.

[11]  M. Kuo,et al.  High incidence of autoantibodies in Taiwanese patients with oral submucous fibrosis. , 2002, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[12]  P. Chou,et al.  Comparison of hepatitis B virus and hepatitis C virus prevalence and risk factors in a community-based study. , 2002, The American journal of tropical medicine and hygiene.

[13]  L. Y. Wang,et al.  Virologic factors related to interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C. , 2000, European journal of endocrinology.

[14]  G. Panarello,et al.  Hepatitis C virus risk: a hepatitis C virus related syndrome , 2000, Journal of internal medicine.

[15]  Chien-Jen Chen,et al.  Epidemiology of hepatitis B virus infection in the Asia–Pacific region , 2000, Journal of gastroenterology and hepatology.

[16]  C. Chiang,et al.  Association of HLA-te22 antigen with anti-nuclear antibodies in Chinese patients with erosive oral lichen planus. , 2000, Proceedings of the National Science Council, Republic of China. Part B, Life sciences.

[17]  J. Piette,et al.  Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. , 2000, Medicine.

[18]  F. Bianchi,et al.  Auto-antibodies in hepatitis C. , 1999, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[19]  W. Chuang,et al.  A hyperendemic community of hepatitis B virus and hepatitis C virus infection in Taiwan. , 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[20]  J. Goudsmit,et al.  Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters. , 1998, Virology.

[21]  F. Chang,et al.  Clinical significance of serum auto‐antibodies in Chinese patients with chronic hepatitis C: Negative role of serum viral titre and genotype , 1998, Journal of gastroenterology and hepatology.

[22]  G. Bianchi,et al.  Serum autoantibodies in chronic hepatitis C: Comparison with autoimmune hepatitis and impact on the disease profile , 1997, Hepatology.

[23]  A. Czaja,et al.  Histological findings in chronic hepatitis C with autoimmune features , 1997, Hepatology.

[24]  Chien-Jen Chen,et al.  Different viral aetiology of hepatocellular carcinoma between two hepatitis B and C endemic townships in Taiwan , 1997, Journal of gastroenterology and hepatology.

[25]  P. Bedossa,et al.  Natural history of liver fibrosis progression in patients with chronic hepatitis C , 1997, The Lancet.

[26]  D. V. van Thiel,et al.  A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases. , 1997, Hepato-gastroenterology.

[27]  C. Rice,et al.  The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. , 1997, Journal of immunology.

[28]  R. Mcmurray,et al.  Hepatitis C virus infection and autoimmunity. , 1997, Seminars in arthritis and rheumatism.

[29]  S. Hadziyannis.  The spectrum of extrahepatic manifestations in hepatitis C virus infection , 1997, Journal of viral hepatitis.

[30]  H. Bonkovsky,et al.  High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C , 1995, Hepatology.

[31]  J. Yen,et al.  Malignant pheochromocytoma associated with Jaccoud's-type arthropathy, Raynaud's phenomenon, positive antinuclear antibody and rheumatoid factor. , 1994, Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences.

[32]  M. Sakamoto,et al.  Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. , 1993, The Journal of general virology.

[33]  M A Gerber,et al.  The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. , 1992, The New England journal of medicine.

[34]  Jaw-Ching Wu,et al.  Seroepidemiology of hepatitis C virus infection in Taiwan , 1991, Hepatology.

[35]  Chien-Jen Chen,et al.  Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. , 1990, The Journal of infectious diseases.

[36]  R. White,et al.  Clinical significance and interpretation of antinuclear antibodies. , 1987, The Western journal of medicine.

[37]  M. Lenzi,et al.  Immunomorphological characterisation of antinuclear antibodies in chronic liver disease. , 1985, Journal of clinical pathology.

[38]  Neil Kaplowitz,et al.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis , 1981, Hepatology.

[39]  M. Manns,et al.  Autoimmunity and extrahepatic manifestations in hepatitis C virus infection. , 1999, Journal of hepatology.